Martingale Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Martingale Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$863K	Hold	204,991	–	–	0.02%	562
2026 Q1	$720K	Buy	+204,991	New	+$840K	0.02%	573
2024 Q1	–	Sell	-139,858	Closed	-$1.6M	–	835
2023 Q4	$1.6M	Sell	139,858 -140	-0.1%	-$1.39K	0.03%	339
2023 Q3	$1.35M	Hold	139,998	–	–	0.03%	355
2023 Q2	$1.49M	Buy	139,998 +5,706	+4%	+$61.3K	0.03%	342
2023 Q1	$1.41M	Buy	134,292 +2,702	+2%	+$30.3K	0.03%	347
2022 Q4	$1.63M	Buy	131,590 +2,837	+2%	+$32.2K	0.03%	316
2022 Q3	$1.33M	Buy	128,753 +3,703	+3%	+$42K	0.03%	355
2022 Q2	$1.44M	Buy	125,050 +28,902	+30%	+$340K	0.03%	361
2022 Q1	$1.21M	Buy	+96,148	New	+$1.1M	0.02%	428

Other funds holding IRWD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Martingale Asset Management's IRWD Position: Q2 2026 in Review

Martingale Asset Management held its Ironwood Pharmaceuticals (IRWD) position steady in Q2 2026 at 204,991 shares worth $863K. The position accounts for 0.02% of the portfolio, ranked #562.

Martingale Asset Management first reported a position in IRWD in Q1 2022 and has held it in 10 quarters since. The position peaked at $1.63M in Q4 2022. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

Martingale Asset Management held 204,991 shares of Ironwood Pharmaceuticals worth $863K as of Q2 2026.
Martingale Asset Management left its Ironwood Pharmaceuticals share count unchanged in Q2 2026.
Ironwood Pharmaceuticals made up 0.02% of Martingale Asset Management's portfolio in Q2 2026, its #562 holding.
Martingale Asset Management first reported a position in Ironwood Pharmaceuticals in Q1 2022 and has held it in 10 quarters since.
Martingale Asset Management's Ironwood Pharmaceuticals position peaked at $1.63M in Q4 2022.
212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Martingale Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.